+ Watch HNSN
on My Watchlist
The Company develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.
Closed and re-opened to more accurately reflect my actual start price for a longer term hold.Actually in at $2.20, but wil likely buy a little more on market dips.
Will probably buy some more next week, if it stays down in this range. Not going anywhere quickly, but drop to this level is in "sympathy" with MAKO, not because it is going under. This is a longer term hold.JMO and worth exactly what I am charging for it.
Wish it would drop about 10%, so I could finish out my desired position for a longer term hold. Want to be in at no more than $2.00 for the longer term. Won't go up and won't go down, so for now I will just wait and watch. Will take some time to get to where it will be a "good" investment, but I believe it will in time. Not a large percentage of my portfolio.JMO and worth exactly what I am charging for it.
I got my wish with this after Q2 results drop, so went ahead and filled my position for a longer term hold. Now in at $1.98.Anything could happen with the share price in the intermediate term, but I believe in the longer term, this will prove to be a good investment. Only about 2% of my portfolio, so I can afford to wait and watch to see how things develop. JMO and worth exactly what I am charging for it.
Ok. I filled my position, you can stop going down now.:)
Bought a little more when it was down earlier, so now in at $1.86.Have more than I want now, so if it reaches or gets a little closer to my start price, I will likely sell some. It seems mostly to be moving up or down when MAKO does. After I lighten my position some, I will just hold and wait for the longer term.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions